Piper Sandler analyst Adam Maeder raised the firm’s price target on Intuitive Surgical (ISRG) to $595 from $575 and keeps an Overweight rating on the shares. The firm reported a strong Q2 ahead of consensus on both the top and bottom line. Additionally, management raised its 2025 procedure guidance from +15%-17% year-over-year to +15.5%-17%, which Piper believes leaves room for further upside to materialize this year.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical: Strong Performance and Promising Growth Prospects Justify Buy Rating
- Intuitive Surgical’s Strong Performance and Growth Prospects Justify Buy Rating
- Intuitive Surgical price target raised to $599 from $559 at Wells Fargo
- Intuitive Surgical’s Strong Financial Performance and Growth Prospects Justify Buy Rating
- Intuitive Surgical’s Strong Q2 Performance and Strategic Expansions Justify Buy Rating